1. /
  2. Our work /
  3. Projects /
  4. Analysis of trends in non-fatal overdose among clients attending the Sydney Medically Supervised Injecting Centre, 2001–2024

Analysis of trends in non-fatal overdose among clients attending the Sydney Medically Supervised Injecting Centre, 2001–2024

Open to students

Non-fatal opioid overdose is one of the most important predictors of fatal overdose. However, it is still poorly understood. Injecting drug use is associated with high rates of morbidity due to non-fatal overdose, yet data on the circumstances surrounding non-fatal overdose are sparse in Australia.

Health service data from the Sydney Medically Supervised Injecting Centre (MSIC) provides an extremely valuable opportunity to gain greater insight into the circumstances surrounding non-fatal overdose among people who inject drugs.

The Sydney MSIC collects demographic data, data on drug injected, data on adverse events (including overdose and interventions administered) and the risk factors associated with these events (e.g. use of other substances, lowered tolerance to drug use etc).

This project is open to students

View 56 more

Quantitative data analysis

This research aims to characterise trends over time in non-fatal overdose among clients attending the MSIC (2001-2024) and to determine risk factors associated with these overdoses to assist in identifying who may be at higher risk of overdose and at what points in time.  

Findings will be of clinical relevance for the MSIC in better understanding the trends and the points in time when clients may be at greater risk of overdose.

Students will gain skills in quantitative data analysis.

Essential criteria

See minimum entry requirements on the Monash University website.

Project contacts

Dr Amanda Roxburgh

Dr Amanda Roxburgh

Senior Research Fellow
View profile
Professor Paul Dietze

Professor Paul Dietze

Program Director, Disease Elimination; Professor and Program Leader, National Drug Research Institute (NDRI)
View profile

Project team

Dr Amanda Roxburgh

Dr Amanda Roxburgh

Senior Research Fellow
View profile
Professor Paul Dietze

Professor Paul Dietze

Program Director, Disease Elimination; Professor and Program Leader, National Drug Research Institute (NDRI)
View profile
L3 MEETINGROOM2 0406 Cropped

Why study at Burnet

When you study with us, you broaden your impact working across our 3 institute-wide programs:

  • Disease Elimination
  • Health Security and Pandemic Preparedness
  • Women's, Children's and Adolescents' Health.

Train with internationally recognised experts in a structured student support system.

Gain a holistic research experience along the way.

On this page